Guinness, L; Harker, M; Martin, N; Greco, G; Borghi, J; Vickerman, P; (2013) Oral presentation: Quality and consistency of costing in the economic evaluation of harm reduction programmes for injecting drug users. [Conference or Workshop Item] https://researchonline.lshtm.ac.uk/id/eprint/1343292

Martin, NK; Hickman, M; Miners, A; Hutchinson, SJ; Taylor, A; Vickerman, P; (2013) COST-EFFECTIVENESS OF INCREASING HCV CASE-FINDING FOR PEOPLE WHO INJECT DRUGS VIA DRIED BLOOD SPOT TESTING IN ADDICTION SERVICES AND PRISONS. [Conference or Workshop Item] https://researchonline.lshtm.ac.uk/id/eprint/1229264 Full text not available from this repository.

Martin, NK; Vickerman, P; Clements, A; Cramp, M; de Angeles, D; Dillon, JF; Fahey, S; Foster, GR; Goldberg, DJ; Gordon, F; +7 more... Hutchinson, SJ; Irving, W; Lewis, H; Ryder, S; Ustainowski, A; Vilar, J; Hickman, M; (2013) ARE CURRENT TREATMENT RATES SUFFICIENT TO REDUCE HCV PREVALENCE AMONG PEOPLE WHO INJECT DRUGS? MODEL PROJECTIONS IN SEVEN UK SETTINGS. [Conference or Workshop Item] https://researchonline.lshtm.ac.uk/id/eprint/1229346 Full text not available from this repository.

Martin, NK; Vickerman, P; Grebely, J; Hellard, M; Hutchinson, SJ; Lima, VD; Foster, GR; Dillon, JF; Goldberg, DJ; Dore, GJ; +1 more... Hickman, M; (2013) HCV treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals. Hepatology (Baltimore, Md), 58 (5). pp. 1598-609. ISSN 0270-9139 DOI: https://doi.org/10.1002/hep.26431 Full text not available from this repository.